Published in Int J Legal Med on January 01, 1995
Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism. Int J Legal Med (2010) 0.97
Utility of desmin and a Masson's trichrome method to detect early acute myocardial infarction in autopsy tissues. Int J Clin Exp Pathol (2009) 0.89
High prevalence of acute myocardial damage in a hospital necropsy series, shown by C9 immunohistology. J Clin Pathol (1998) 0.84
Early markers for myocardial ischemia and sudden cardiac death. Int J Legal Med (2016) 0.83
A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers. J Transl Med (2014) 0.82
Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood (2001) 2.05
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol (2009) 1.58
Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia (2004) 1.46
Treatment results of advanced neuroblastoma with the first Japanese study group protocol. Study Group of Japan for Treatment of Advanced Neuroblastoma. J Pediatr Hematol Oncol (1999) 1.35
Permeation of manganese, cadmium, zinc, and beryllium through calcium channels of an insect muscle membrane. Science (1977) 1.22
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia. Leukemia (2010) 1.19
PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant (2013) 1.09
Experience with International Neuroblastoma Staging System and Pathology Classification. Br J Cancer (2002) 1.06
Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation. Bone Marrow Transplant (2003) 1.06
Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant (2006) 1.05
Calcium and potassium currents in spermatogenic cells dissociated from rat seminiferous tubules. J Physiol (1984) 0.99
Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant (2003) 0.99
Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet (2000) 0.97
Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood (2001) 0.97
Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood. Bone Marrow Transplant (2000) 0.92
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study. Med Pediatr Oncol (2001) 0.91
Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation. Bone Marrow Transplant (2002) 0.89
Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes Control (1998) 0.88
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry. Bone Marrow Transplant (2012) 0.87
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia. Bone Marrow Transplant (2013) 0.86
Zinc-dependent action potentials in giant neurons of the snail, Euhadra quaestia. J Membr Biol (1979) 0.86
Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transplant (2002) 0.86
Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan. Med Pediatr Oncol (1998) 0.85
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant (1999) 0.85
Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT from an HLA-matched sibling donor in Japan. Bone Marrow Transplant (2012) 0.85
Second allogeneic hematopoietic SCT for relapsed ALL in children. Bone Marrow Transplant (2012) 0.85
Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood (1998) 0.84
Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol (2014) 0.84
Successful allogeneic stem cell transplantation from an unrelated donor for aggressive Epstein-Barr virus-associated clonal T-cell proliferation with hemophagocytosis. Int J Hematol (2001) 0.83
Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Transplant (2001) 0.83
On the two subdivisions and intrinsic synaptic connexions in the submandibular ganglion of the rat. J Physiol (1984) 0.83
Clonal change of infiltrating T-cells in children with familial hemophagocytic lymphohistiocytosis: possible association with Epstein-Barr virus infection. Cancer (1999) 0.82
Salvage allogeneic hematopoietic SCT for primary graft failure in children. Bone Marrow Transplant (2013) 0.82
The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol (2009) 0.82
Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplant (2007) 0.81
Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses. J Leukoc Biol (2000) 0.81
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate. Leukemia (2004) 0.81
Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant (1999) 0.81
Existence of rolipram-sensitive phosphodiesterase in rat megakaryocyte. Br J Pharmacol (1993) 0.81
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic hematopoietic stem cell transplant. Leukemia (2011) 0.81
Unrelated donor bone marrow transplantation for 100 pediatric patients: a single institute's experience. Bone Marrow Transplant (2005) 0.80
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34) dramatically improves the patient prognosis: a matched-pair analysis. Leukemia (2011) 0.80
Altered developmental changes of neuromuscular junction in hypo- and hyperthyroid rats. J Physiol (1982) 0.79
Encouraging results of preserving ovarian function after allo-HSCT with RIC. Bone Marrow Transplant (2011) 0.79
[CD34+ progenitor cell transplantation from HLA-mismatched donors to two patients with chronic active Epstein-Barr virus infection]. Rinsho Ketsueki (2001) 0.78
Lactoferrin for gut GVHD. Bone Marrow Transplant (2001) 0.77
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR. Bone Marrow Transplant (2012) 0.77
M-CSF attenuates severity of chronic GVHD after unrelated BMT. Bone Marrow Transplant (2011) 0.77
Calcium dependent action potentials in skeletal muscle fibres of a beetle larva, Xylotrupes dichotomus. J Insect Physiol (1977) 0.77
Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan. Bone Marrow Transplant (2003) 0.77
t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines. Genes Chromosomes Cancer (2001) 0.77
Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease. Int J Hematol (2005) 0.76
Phenotypic analysis in a case of hydroa vacciniforme-like eruptions associated with chronic active Epstein-Barr virus disease of γδ T cells. Br J Dermatol (2012) 0.76
A novel mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a blood donor with the Am B phenotype. Vox Sang (2014) 0.76
[Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy]. Rinsho Ketsueki (1997) 0.76
Differential effects of adenosine antagonists in two models of parkinsonian tremor. Pharmacol Biochem Behav (2009) 0.75
Successful treatment of JMML with related bone marrow transplantation after reduced-intensity conditioning. Bone Marrow Transplant (2005) 0.75
[Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors]. Rinsho Ketsueki (2000) 0.75
[Treatment of acute nonlymphocytic leukemia in children]. Rinsho Ketsueki (1982) 0.75
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program. Bone Marrow Transplant (2010) 0.75
[Current concept of hemophagocytic syndrome]. Rinsho Ketsueki (1999) 0.75
Colostrum and severe gut GVHD. Bone Marrow Transplant (1998) 0.75
[Aggressive natural killer cell leukemia/lymphoma--possible existence of a new clinical entity originating from the third lineage of lymphoid cells]. Rinsho Ketsueki (1989) 0.75
[High dose cytosine arabinoside (HDCA) in children with refractory leukemia or malignant lymphoma (3 g/m2 vs 1.5 g/m2)]. Rinsho Ketsueki (1985) 0.75
Ophthalmic findings in a case of hemophagocytic syndrome. Am J Ophthalmol (1997) 0.75
Endoscopic observations of the postoperative gastric remnant with special reference to changes in the gastroenterostomy stoma. Osaka City Med J (1970) 0.75
[The clinical significance of minimal residual disease of acute leukemia with t(4;11) (q21;q23)]. Rinsho Ketsueki (1996) 0.75
[Natural killer cell lymphoma having a nodular shadow in the lung as an initial finding, developed to leukemia complicated with hemophagocytic syndrome at the time of relapse]. Rinsho Ketsueki (1996) 0.75
[B lineage non-Hodgkin's lymphoma switched to acute monocytic leukemia]. Rinsho Ketsueki (1987) 0.75
[Hypocellular acute leukemia]. Ryoikibetsu Shokogun Shirizu (1998) 0.75
[LGL lymphoma]. Rinsho Byori (1996) 0.75
Eosinophilic pustular folliculitis in association with nevoid basal cell carcinoma syndrome. Acta Derm Venereol (2001) 0.75
[Chronic active EB virus infection and granular lymphocytes proliferative disorders in Japan]. Rinsho Ketsueki (1996) 0.75
[Clinical study of imipenem/cilastatin sodium in children with severe infections]. Jpn J Antibiot (1990) 0.75
Cord blood transplantation from sibling donors in Japan. Report of the national survey. Int J Hematol (1998) 0.75
[EB virus infection]. Nihon Rinsho Meneki Gakkai Kaishi (1996) 0.75
The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis. Bone Marrow Transplant (2013) 0.75
Pneumococcal arthritis affects performance status in patients with chronic GVHD of the skin following allogeneic bone marrow transplantation. Int J Hematol (2001) 0.75
[Acute lymphocytic leukemia with unusual azurophilic granules: case report and review of literature]. Rinsho Ketsueki (1988) 0.75
Aggressive granular lymphocyte leukemia of natural killer cell type in an elderly patient. Intern Med (1993) 0.75
CD34+ progenitor cell transplantation from two HLA-mismatched healthy fathers to two infants with severe aplastic anemia. Int J Hematol (1998) 0.75
[High-dose cytosine arabinoside therapy in children with non-Hodgkin's lymphoma--effective intensification and CNS prophylaxis]. Rinsho Ketsueki (1987) 0.75
[Hairy cell leukemia of European-American type with dual T and B-cell phenotype]. Rinsho Ketsueki (1989) 0.75
Initiation of Ca-spikes from an insect muscle fiber immersed in a low pH saline solution containing carboxylic anions. Life Sci (1977) 0.75
Eradication of human T-lymphotropic virus type 1 by allogeneic bone-marrow transplantation. Lancet (1998) 0.75
Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in children. Bone Marrow Transplant (2006) 0.75
HTLV-I associated myelopathy (HAM) after blood transfusion in a patient with CD2+ hairy cell leukemia. Am J Clin Pathol (1991) 0.75
[Epstein-Barr virus-infected T-cell malignancy in an adult patient with Behçet's disease-like symptoms]. Rinsho Ketsueki (1997) 0.75
[Maturation therapy for advanced neuroblastoma-therapeutic effects and problems]. Gan To Kagaku Ryoho (1982) 0.75
Different Clinical Phenotypes in 2 Siblings With X-Linked Severe Combined Immunodeficiency. J Investig Allergol Clin Immunol (2016) 0.75
Treatment of pediatric malignant tumors with VP-16. West Japan Pediatric Oncology Group. Acta Paediatr Jpn (1990) 0.75